Validation of the French Version of the Fremantle Back Awareness Questionnaire (FreBAQ) in Patients With Chronic Low Back Pain (FreBAQ)

In patients with chronic low back pain, the Fremantle Back Awareness Questionnaire (FreBAQ) measures the duration and intensity of pain and functional limitations. The FreBAQ is a simple tool created to assess disturbances in the body representation of the back, and the only one existing in chronic low back pain. It is a 9-item self-questionnaire in which each item is measured on a 5-point Likert scale ranging from "Never (score of 0)" to "Always (score of 4)". It assesses neglect, perceived body image of the back, accuracy in proprioceptive perception of back movements.

The psychometric properties of the FreBAQ in English, Japanese, Dutch, Turkish and German are validated and acceptable; however, they have never been studied in French and no validated version of this questionnaire in French exists.

The study investigators hypothesize that the French version of the FreBAQ has good psychometric qualities, allowing it to be used in the French chronic low back pain population.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Nîmes, France
        • CHU de NIMES

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients with chronic low back pain defined as pain localized between the edge of the last lower ribs and the intergluteal groove (17) for more than 3 months followed in the Physical Medicine and Rehabilitation Department of the CHU of Nîmes and persons recruited among the members of the service and their entourage, as well as all patients coming for consultation in the service with no history of chronic low back pain and lumbar VAS < 2 for more than 3 months.

Description

Inclusion Criteria:

  • Subject with no history of chronic low back pain and with a lumbar VAS <2 for more than 3 months.
  • Patient with chronic low back pain: pain localized between the edge of the last lower ribs and the intergluteal groove (17) for more than 3 months.
  • Patient with a lumbar VAS > 2 for more than 3 months.
  • Patient whose low back pain is of common origin (no underlying organic etiology).
  • In case of lumbar-radicular pain, patient with a VAS (lumbar) > VAS (leg)
  • Patient who speaks and understands French
  • Patient with no history of arthrodesis or lumbar disc prosthesis
  • Subject affiliated or beneficiary of a health insurance plan.
  • The patient must have given their free and informed consent and signed the consent form

Exclusion Criteria:

  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patient pregnant, parturient or breastfeeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with low back pain
Subjects will take the FreBAQ questionnaire at Day 0 and a subgroup of 35 controls and 15 patients will take the same questionnaire at Day 7
Controls
Subjects will take the FreBAQ questionnaire at Day 0 and a subgroup of 35 controls and 15 patients will take the same questionnaire at Day 7

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pre-test of French version of FreBAQ on 20 representative patients
Time Frame: Baseline
9-item self-administered questionnaire newly translated into French using a standard translation-retro-translation system, each item measured on a 5-point Likert scale ranging from "Never (score of 0)" to "Always (score of 4)
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FreBAQ score
Time Frame: Day 0
a 9-item self-administered questionnaire, each item measured on a 5-point Likert scale ranging from "Never (score of 0)" to "Always (score of 4)
Day 0
FreBAQ score in a subgroup of 50 subjects (35 patients and 15 controls)
Time Frame: Day 7
a 9-item self-administered questionnaire, each item measured on a 5-point Likert scale ranging from "Never (score of 0)" to "Always (score of 4)
Day 7
Evaluation of the internal consistency of the French version of the FreBAQ
Time Frame: Day 0
Analyzed by calculating Cronbach's alpha.
Day 0
Evaluation of the unidimensionality of the French version of the FreBAQ
Time Frame: Day 0
Analyzed using principal component analysis methods
Day 0
Assessment of the reliability (test-retest) of the questionnaire in French
Time Frame: Day 7
Measurement of the reliability of the questionnaire in French between the initial test and a test at Day 7: calculation of Bland & Altman's limits of agreement,
Day 7
Assessment of the reproducibility (test-retest) of the questionnaire in French
Time Frame: Day 7
Measurement of the reproducibility of the questionnaire in French between the initial test and a test at Day 7: calculation of the intra-class correlation coefficient
Day 7
Assessment of the discriminant validity of the questionnaire in French
Time Frame: Day 0
Comparison of scores between control subjects and chronic low back pain patients by calculating the area under the ROC curve
Day 0
Assessment of the concurrent validity
Time Frame: Day 0
Correlation of the French questionnaire score with the duration of low back pain
Day 0
Correlation of the French questionnaire score with lumbar visual analog scale (VAS) at rest
Time Frame: Day 0
FreBAQ score compared with VAS result
Day 0
Correlation of the French questionnaire score with lumbar VAS in movement
Time Frame: Day 0
FreBAQ score compared with VAS result
Day 0
Correlation of the French questionnaire score with disability
Time Frame: Day 0
FreBAQ score compared with Oswestry Disability Index - a 10-section questionnaire with a results calculated as a percentage
Day 0
Correlation of the French questionnaire score with false beliefs
Time Frame: Day 0
FreBAQ score compared with back beliefs questionnaire - a 14-tem questionnaire on a 0-5 scale
Day 0
Correlation of the French questionnaire score with fear avoidance beliefs
Time Frame: Day 0
FreBAQ score compared with Fear Avoidance Belief Questionnaire - 16-item questionnaire scored between 0-6. Scale 1 = beliefs about work with a score ranging from 0 -42; Scale 2 = beliefs about physical activity with a score ranging from 0-24
Day 0
Correlation of the French questionnaire score with kinesiophobia
Time Frame: Day 0
FreBAQ score compared with Tampa scale of Kinesiophobia - total score 68, with a cut-off of 40 for significant kinesiophobia
Day 0
Correlation of the French questionnaire score with catastrophism
Time Frame: Day 0
FreBAQ score compared with Pain Catastrophizing Scale - a 13-item questionnaire on a 0-4 Likert scale
Day 0
Correlation of the French questionnaire score with anxiety and depression
Time Frame: Day 0
FreBAQ score compared with Hospital Anxiety and Depression Scale - a 14-item questionnaire on a 0-9 Likert scale
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 23, 2022

Primary Completion (Actual)

April 28, 2023

Study Completion (Actual)

April 28, 2023

Study Registration Dates

First Submitted

June 3, 2021

First Submitted That Met QC Criteria

June 11, 2021

First Posted (Actual)

June 18, 2021

Study Record Updates

Last Update Posted (Estimate)

May 4, 2023

Last Update Submitted That Met QC Criteria

May 3, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIMAO/2020-2/AH-1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Pain Questionnaire

3
Subscribe